Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Trimmed to $95 at Chardan Capital Markets

May 5, 2017 10:07 AM
Chardan Capital Markets lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $95.00 (from $97.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles